KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 0.2.

  • Eli Lilly's FCF Payout Ratio fell 5978.76% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year decrease of 8264.8%. This contributed to the annual value of 1.24 for FY2024, which is 7575.83% down from last year.
  • Latest data reveals that Eli Lilly reported FCF Payout Ratio of 0.2 as of Q3 2025, which was down 5978.76% from 0.97 recorded in Q2 2025.
  • Eli Lilly's 5-year FCF Payout Ratio high stood at 8.62 for Q1 2025, and its period low was 9.57 during Q2 2023.
  • In the last 5 years, Eli Lilly's FCF Payout Ratio had a median value of 0.6 in 2021 and averaged 1.01.
  • Per our database at Business Quant, Eli Lilly's FCF Payout Ratio tumbled by 98011.78% in 2023 and then skyrocketed by 57935.97% in 2024.
  • Eli Lilly's FCF Payout Ratio (Quarter) stood at 0.39 in 2021, then soared by 93.92% to 0.76 in 2022, then plummeted by 196.76% to 0.74 in 2023, then soared by 262.25% to 1.19 in 2024, then crashed by 83.32% to 0.2 in 2025.
  • Its FCF Payout Ratio stands at 0.2 for Q3 2025, versus 0.97 for Q2 2025 and 8.62 for Q1 2025.